Drug Prices: Ufc-Que Choix Denounces "Drifts" and Demands More Transparency

Sud Ouest

Center

Factuality

Ownership

Citing the example of the Keytruda, the consumer association points to "the drifts of the pharmaceutical market" and calls for better price regulation of innovative treatments LUFC-What to choose

franceinfo.fr

Lean Left

Factuality

Ownership

According to the consumer association, some treatments, including innovative anti-cancer treatments, could cost far less than the amounts charged to Medicare.

TF1 INFO

Center

Factuality

Ownership

Maud Descamps tells us about the UFC-Que Choisir, which denounces the prohibitive price of certain medicines, including Keytruda. It is an anti-cancer treatment, manufactured by Merck & Co. It is necessary to count 2,200 euros for a bottle of 100 mg. (Conso and trends).

Femme Actuelle

Factuality

Ownership

UFC-Que Choisir denounces the exorbitant and opaque price of certain drugs such as Keytruda®, which weakens the French healthcare system by funding laboratories to the detriment of equitable access to care.

quechoisir.org

Factuality

Ownership

The prices of the new treatments have become so exorbitant that they endanger access to care. Illustration with the number 1 of health expenditures in France, the Keytruda, an anticancer emblematic of the drifts of the system.